{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:26:22Z","timestamp":1791901582967,"version":"4.3.4"},"reference-count":149,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:00:00Z","timestamp":1701475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathophysiology"],"abstract":"<jats:p>The pathophysiology of myasthenia gravis (MG) has been largely elucidated over the past half century, and treatment methods have advanced. However, the number of cases of childhood-onset MG is smaller than that of adult MG, and the treatment of childhood-onset MG has continued to be based on research in the adult field. Research on pathophysiology and treatment methods that account for the unique growth and development of children is now desired. According to an epidemiological survey conducted by the Ministry of Health, Labour and Welfare of Japan, the number of patients with MG by age of onset in Japan is high in early childhood. In recent years, MG has been reported from many countries around the world, but the pattern of the number of patients by age of onset differs between East Asia and Western Europe, confirming that the Japanese pattern is common in East Asia. Furthermore, there are racial differences in autoimmune MG and congenital myasthenic syndromes according to immunogenetic background, and their pathophysiology and relationships are gradually becoming clear. In addition, treatment options are also recognized in different regions of the world. In this review article, I will present recent findings focusing on the differences in pathophysiology.<\/jats:p>","DOI":"10.3390\/pathophysiology30040043","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T13:45:49Z","timestamp":1701524749000},"page":"599-617","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background"],"prefix":"10.3390","volume":"30","author":[{"given":"Masatoshi","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Uwajima City Hospital, Uwajima 798-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1113\/jphysiol.1964.sp007495","article-title":"An electrophysiological investigation of neuromuscular transmission in myasthenia gravis","volume":"174","author":"Elmqvist","year":"1964","journal-title":"J. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/003693306000501001","article-title":"Myasthenia gravis: A new hypothesis","volume":"5","author":"Simpson","year":"1960","journal-title":"Scott. Med. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acn3.51792","article-title":"Mortality of myasthenia gravis: A national population-based study in China","volume":"10","author":"Zhang","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yoshikawa, H., Adachi, Y., Nakamura, Y., Kuriyama, N., Murai, H., Nomura, Y., Sakai, Y., Iwasa, K., Furukawa, Y., and Kuwabara, S. (2018). Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0274161"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1749-6632.1981.tb33766.x","article-title":"Observations of the natural history of myasthenia gravis and the effect of thymectomy","volume":"377","author":"Oosterhuis","year":"1981","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Carr, A.S., Cardwell, C.R., McCarron, P.O., and McConville, J. (2010). A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol., 10.","DOI":"10.1186\/1471-2377-10-46"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Dresser, L., Wlodarski, R., Rezania, K., and Soliven, B. (2021). Myasthenia gravis: Epidemiology, pathophysiology and clinical manifestations. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112235"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000477733","article-title":"Incidence of autoimmune myasthenia gravis in a health maintenance organization in Buenos Aires, Argentina","volume":"48","author":"Bettini","year":"2017","journal-title":"Neuroepidemiology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/ane.13596","article-title":"Epidemiological profile of myasthenia gravis in South Korea using the national health insurance database","volume":"145","author":"Park","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","article-title":"Myasthenia gravis: A changing pattern of incidence","volume":"257","author":"Casetta","year":"2010","journal-title":"J. Neurol."},{"key":"ref_13","first-page":"497","article-title":"Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"Mt. Sinai J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/WNL.37.12.1854","article-title":"Myasthenia gravis: Population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians","volume":"37","author":"Chiu","year":"1987","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2011.03.004","article-title":"Characteristics of myasthenia gravis according to onset-age: Japanese Nationwide survey","volume":"305","author":"Murai","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10072-012-1157-z","article-title":"Clinical features of myasthenia gravis in southern China: A retrospective review of 2154 cases over 22 years","volume":"34","author":"Huang","year":"2013","journal-title":"Neurol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00415-015-7638-2","article-title":"Long-term outcome of 424 childhood-onset myasthenia gravis patients","volume":"262","author":"Gui","year":"2015","journal-title":"J. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Chou, C.-C., CHEESE study group, Su, I.-C., Chou, I.-J., Lin, J.-J., Lan, S.-Y., Wang, Y.-S., Kong, S.-S., Chen, Y.-J., and Hsieh, M.-Y. (2019). Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: A case control study. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1397-0"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1177\/0883073816666206","article-title":"Juvenile myasthenia gravis in Korea: Subgroup analysis according to sex and onset age","volume":"31","author":"Lee","year":"2016","journal-title":"J. Chil. Neurol."},{"key":"ref_20","first-page":"404101","article-title":"Juvenile myasthenia gravis: A pediatric perspective","volume":"2011","author":"Finnis","year":"2011","journal-title":"Autoimmune Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejpn.2017.04.003","article-title":"Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort","volume":"21","author":"Popperud","year":"2017","journal-title":"Eur. J. Pediatr. Neurol."},{"key":"ref_22","first-page":"235","article-title":"Childhood-onset myasthenia gravis","volume":"54","author":"Hayashi","year":"2022","journal-title":"No Hattatsu"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2019.01.004","article-title":"Incidence and ocular features of pediatric myasthenias","volume":"200","author":"Mansukhani","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nmd.2019.11.008","article-title":"Pediatric myasthenia gravis: Prognostic factors for drug free remission","volume":"30","author":"Vecchio","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"996213","DOI":"10.3389\/fped.2022.996213","article-title":"Clinical characteristics and outcome predictors of a Chinese childhood-onset myasthenia gravis cohort","volume":"10","author":"Yang","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1073\/pnas.0406756101","article-title":"Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia","volume":"101","author":"Vandiedonck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Popperud, T.H., Viken, M.K., Kerty, E., and Lie, B.A. (2017). Juvnile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186383"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: A Swedish population-based study","volume":"77","author":"Fang","year":"2015","journal-title":"J. Int. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mus.26507","article-title":"Refractory myasthenia gravis: Characteristics of a Portuguese cohort","volume":"60","author":"Santos","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clineuro.2012.04.001","article-title":"Association of HLA-DR\/DQ polymorphism with myasthenia gravis in Tunisian patients","volume":"115","author":"Klai","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10072-015-2235-9","article-title":"The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population","volume":"36","author":"Feng","year":"2015","journal-title":"Neurol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1172\/JCI114724","article-title":"HLA antigen in Japanese patients with myasthenia gravis","volume":"86","author":"Matsuki","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2003.10.004","article-title":"A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan","volume":"110","author":"Shinomiya","year":"2004","journal-title":"Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0198-8859(89)90095-5","article-title":"Comparative mapping of the human major histocompatibility complex in different racial groups by pulsed field gel electrophoresis","volume":"26","author":"Tokunaga","year":"1989","journal-title":"Hum. Immnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.410210309","article-title":"Heteropgeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types","volume":"21","author":"Kida","year":"1987","journal-title":"Ann. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-5728(88)90064-1","article-title":"Involvement of HLA in clinical courses of myasthenia gravis","volume":"18","author":"Hayashi","year":"1988","journal-title":"J. Neuroimmunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1212\/WNL.16.5.431","article-title":"Myasthenia gravis: Evaluation of treatment in 1355 patients","volume":"16","author":"Perlo","year":"1966","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: Decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Koneczny, I., and Herbst, R. (2019). Myasthenia gravis: Pathogenic effects of autoantibodies on neuromuscular architecture. Cells, 8.","DOI":"10.3390\/cells8070671"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1083\/jcb.114.1.125","article-title":"Neural factors regulate AChR submit mRNAs at rat neuromuscular synapses","volume":"114","author":"Witzemann","year":"1991","journal-title":"J. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fnmol.2020.00086","article-title":"Myasthenia gravis: From the viewpoint of pathogenicity focusing on acetylcholine receptor clustering, trans-synaptic homeostasis and synaptic stability","volume":"13","author":"Takamori","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"610964","DOI":"10.3389\/fnmol.2020.610964","article-title":"The neuromuscular junction in health and disease: Molecular mechanisms governing synaptic formation and homeostasis","volume":"13","author":"Cossins","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ohkawara, B., Ito, M., and Ohno, K. (2021). Secreted signaling molecules at the neuromuscular junction in physiology and pathology. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052455"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.186.4158.55","article-title":"Serum globulin in myasthenia gravis: Inhibition of a-bungarotoxin binding to acetylcholine receptors","volume":"186","author":"Almon","year":"1974","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(75)91886-3","article-title":"Myasthenia gravis: A serum factor blocking acetylcholine receptors of the human neuromuscular junction","volume":"1","author":"Bender","year":"1975","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.27.4.307","article-title":"Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model","volume":"27","author":"Engel","year":"1977","journal-title":"Neurology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.79.1.188","article-title":"Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies","volume":"79","author":"Tzartos","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: Past, present, and future","volume":"116","author":"Milani","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1749-6632.1981.tb33731.x","article-title":"Antibody-mediated mechanisms of ACh receptor loss in myasthenia gravis: Clinical relevance","volume":"377","author":"Drachman","year":"1981","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.850793","article-title":"Myasthenic immunoglobulin accelerates acetylcholine receptor degradation","volume":"196","author":"Kao","year":"1977","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.80.13.4089","article-title":"Anti-acetylcholine receptor antibodies directed against the \u03b1-bunbgarotoxin binding site induce a unique form of experimental myasthenia","volume":"80","author":"Gomez","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(83)90022-X","article-title":"Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass","volume":"5","author":"Whiting","year":"1983","journal-title":"J. Neuroimmunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Tuzun","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00005072-198003000-00005","article-title":"Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis","volume":"39","author":"Sahashi","year":"1980","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.39.10.1359","article-title":"Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis","volume":"39","author":"Tsujihata","year":"1989","journal-title":"Neurology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.147.4.973","article-title":"Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis","volume":"147","author":"Lennon","year":"1978","journal-title":"J. Exp. Med."},{"key":"ref_59","first-page":"222","article-title":"Antiacetylcholine receptor antibody in neonatal myasthenia gravis","volume":"135","author":"Donaldson","year":"1981","journal-title":"Am. J. Dis. Child."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.45.3.488","article-title":"Neonatal myasthenia gravis: Report of two cases and review of the literature","volume":"45","author":"Namba","year":"1970","journal-title":"Pediatrics"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.33.2.133","article-title":"Newborn infants to myasthenic mothers: A clinical study and an investigation of acetylcholine receptor antibodies in 17 children","volume":"33","author":"Lefvert","year":"1983","journal-title":"Neurology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2249.1990.tb03296.x","article-title":"Neonatal myasthenia gravis: Antigenic specificities of antibodies in sera from mothers and their infants","volume":"80","author":"Tzartos","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2020.00554","article-title":"Myasthenia gravis can have consequences for pregnancy and the developing child","volume":"11","author":"Gilhus","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199007263230404","article-title":"Estimation of the risk of Thrombocytonia in the offspring of pregnant women with presumed immune thrombocytopenic purpura","volume":"323","author":"Samuels","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02982137","article-title":"Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int. J. Hematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","article-title":"Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen","volume":"346","author":"Vincent","year":"1995","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1172\/JCI119048","article-title":"Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function","volume":"98","author":"Riemersma","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"14426","DOI":"10.1038\/s41598-017-14350-8","article-title":"Characterization of an anti-fetal AChR monoclonal antibopdy isolated from a myasthenia gravis patient","volume":"7","author":"Saxena","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nature Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"ref_72","first-page":"1151","article-title":"Myasthenia gravis patients with anti-MuSK antibodies","volume":"33","author":"Zagar","year":"2009","journal-title":"Coll. Antropol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mus.20854","article-title":"Frequency of seronegativity in adult-acquired generalized myasthenia gravis","volume":"36","author":"Chan","year":"2007","journal-title":"Muscle Nerve"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2009.03.020","article-title":"MuSK-antibody-positive myasthenia gravis in a south Asian population","volume":"284","author":"Chang","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"516211","DOI":"10.3389\/fneur.2020.516211","article-title":"Regional features of MuSK antibody-positive myasthenia gravis in North China","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jocn.2005.04.028","article-title":"MuSK antibody-positive, seronegative myasthenia gravis in Korea","volume":"13","author":"Lee","year":"2006","journal-title":"J. Clin. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2007.01870.x","article-title":"Clinical and experimental features of MuSK antibody positive MG in Japan","volume":"14","author":"Ohta","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1212\/01.wnl.0000223835.51268.12","article-title":"Infantile onset myasthenia gravis with MuSDK antibodies","volume":"67","author":"Murai","year":"2006","journal-title":"Neurology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.braindev.2011.12.014","article-title":"Childhood-onset anti-MuSK antibody positive myasthenia gravis demonstrates a distinct clinical course","volume":"34","author":"Takahashi","year":"2012","journal-title":"Brain Dev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jns.2016.02.031","article-title":"HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients","volume":"363","author":"Kanai","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/ane.12951","article-title":"HLA and MuSK-positive myasthenia gravis: A systemtic review and meta-analysis","volume":"138","author":"Hong","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000506189","article-title":"Myasthenia gravis with anti-muscle-specific tyrosine kinase antibody during pregnancy and risk of neonatal myasthenia gravis: A case report and review of the literature","volume":"12","author":"Inoue","year":"2020","journal-title":"Case Rep. Neurol."},{"key":"ref_84","first-page":"075812","article-title":"Anti-MuSK antibodies in a case of ocular myasthenia gravis","volume":"564","author":"Bennett","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2169\/internalmedicine.51.8196","article-title":"An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up","volume":"51","author":"Hosaka","year":"2012","journal-title":"Int. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.20341","article-title":"Acetylcholine receptors loss and postsynaptic damage in MuSK antibody positive myasthenia gravis","volume":"57","author":"Shiraishi","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Koneczny, I., Cossins, J., Waters, P., Beeson, D., and Vincent, A. (2013). MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080695"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1038\/srep13928","article-title":"Collagen Q and anti-MuSK autoantibody competitively suppress agrin\/LRP4\/MuSK signaling","volume":"5","author":"Otsuka","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamaneurol.2015.0203","article-title":"Clinical features and diagnostic usefulness of antibodies to cultured acetylcholine receptors in the diagnosis of seronegative myasthenia gravis","volume":"72","author":"Huda","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"100876","DOI":"10.1016\/j.lanwpc.2023.100876","article-title":"Fixed cell-based assays for autoantibody detection in myasthenia gravis: A diagnostic breakthrough","volume":"38","author":"Budhram","year":"2023","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J. Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 patients with double-seronegative myasthenia gravis","volume":"69","author":"Tzartos","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Zhang, B., Shen, C., Bealmear, B., Ragheb, S., Xiong, W.-C., Lewis, R.A., Lisak, R.P., and Mei, L. (2014). Autoantibodies to agrin in myasthenia gravis patients. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091816"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuroscience.2018.01.015","article-title":"Induction of anti-agrin antibodies causes myasthenia gravis in mice","volume":"373","author":"Yan","year":"2018","journal-title":"Neuroscience"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mus.26985","article-title":"Clinical features of LRP4\/agrin-antibody-positive myasthenia gravis: A multicenter study","volume":"62","author":"Rivner","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jamaneurol.2016.2277","article-title":"Seronegative myasthenia gravis\u2014A vanishing disorder?","volume":"73","author":"Kaminski","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_101","first-page":"183","article-title":"How to recognize an antibody-mediated autoimmune disease: Criteria","volume":"68","author":"Drachman","year":"1990","journal-title":"Res. Publ. Assoc. Res. Nerv. Ment. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia gravis by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/08820139.2017.1299754","article-title":"Immunization with recombinantly expressed LRP4 induces experimental autoimmune myasthenia gravis in C57BL\/6 mice","volume":"46","author":"Ulsoy","year":"2017","journal-title":"Immunol. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.expneurol.2017.08.006","article-title":"Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis","volume":"297","author":"Mori","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1212\/WNL.0000000000012463","article-title":"Characterization of LRP4\/Agrin antibodies from a patient with myasthenia gravis","volume":"97","author":"Yu","year":"2021","journal-title":"Neurology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndrome: Pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.nmd.2014.09.002","article-title":"Congenital myasthenic syndrome in Japan: Ethnically unique mutations in muscle nicotinic acetylcholine receptor subunits","volume":"25","author":"Azuma","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Ohno, K., Ohkawara, B., Shen, X.-M., Selcen, D., and Engel, A.G. (2023). Clinical and pathologic features of congenital myasthenic syndromes caused by 35 genes\u2014A comprehensive review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043730"},{"key":"ref_111","first-page":"781","article-title":"Anti-acetylcholine receptor antibody in juvenile and adult myasthenia gravis","volume":"28","author":"Hayashi","year":"1986","journal-title":"Acta Paediatr. Jpn."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1038\/srep10193","article-title":"Clinical application of clustered-AChR for the detection SNMG","volume":"5","author":"Zao","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1749-6632.1993.tb22889.x","article-title":"Differences in acetylcholine receptor-antibody interactions between extraocular and extremity muscle fibers","volume":"681","author":"Oda","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.40.11.1663","article-title":"Why are eye muscles frequently involved in myasthenia gravis?","volume":"40","author":"Kaminski","year":"1990","journal-title":"Neurology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1212\/WNL.43.5.983","article-title":"The \u2018embrionic\u2019 gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle","volume":"43","author":"Horton","year":"1993","journal-title":"Neurology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/dbio.1996.0253","article-title":"Maturation of the acetylcholine receptor in skeletal muscle: Regulation of the AChR \u03b3-to-\u03f5 switch","volume":"179","author":"Missias","year":"1996","journal-title":"Dev. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(86)90099-7","article-title":"Motor innervation and acetylcholine receptor distribution of human extraocular muscle fibers","volume":"74","author":"Oda","year":"1986","journal-title":"J. Neurol. Sci."},{"key":"ref_118","first-page":"345","article-title":"Expression of acetylcholine receptor isoforms at extraocular muscle endplates","volume":"37","author":"Kaminski","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2008.04.038","article-title":"How myasthenia gravis alters the safety factor for neuromuscular transmission?","volume":"201\u2013202","author":"Ruff","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1749-6632.2012.06841.x","article-title":"Neuromuscular transmission failure in myasthenia gravis: Decrement of safety factor and susceptibility of extraocular muscle","volume":"1275","author":"Serra","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"834212","DOI":"10.3389\/fneur.2022.834212","article-title":"The epidemiology and phenotypes of ocular manifestations in childhood and juvenile myasthenia gravis: A review","volume":"13","author":"Heckmann","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thorsurg.2018.12.001","article-title":"The role of the thymus in the immune response","volume":"29","author":"Thapa","year":"2019","journal-title":"Thorac. Surg. Clin."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/intimm\/dxy081","article-title":"Thymus machinery for T-cell selection","volume":"31","author":"Kondo","year":"2019","journal-title":"Int. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"eaah6506","DOI":"10.1126\/sciimmunol.aah6506","article-title":"Long-term maintenance of human na\u00efve T cell through in situ homeostasis in lymphoid tissue sites","volume":"1","author":"Thome","year":"2016","journal-title":"Sci. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"Crooke","year":"2019","journal-title":"Immun. Ageing"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1084\/jem.151.1.204","article-title":"Experimental myasthenia gravis: A murine system","volume":"151","author":"Berman","year":"1980","journal-title":"J. Exp. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.128.3.1141","article-title":"Genetic control of experimental autoimmune myasthenia gravis in mice III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors","volume":"128","author":"Christadoss","year":"1982","journal-title":"J. Immunol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/308551a0","article-title":"Nucleotide sequence of mutant I-Abbm12 gene is evidence for genetic exchange between mouse immune response genes","volume":"308","author":"McIntyre","year":"1984","journal-title":"Nature"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00372239","article-title":"Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis","volume":"21","author":"Christadoss","year":"1985","journal-title":"Immunogenet"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4049\/jimmunol.147.5.1484","article-title":"The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor","volume":"147","author":"Bellone","year":"1991","journal-title":"J. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.4049\/jimmunol.146.9.2977","article-title":"Determinant selection in murine experimental autoimmune myasthenia gravis: Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes","volume":"146","author":"Infante","year":"1991","journal-title":"J. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.imlet.2015.10.009","article-title":"Ocular myasthenia gravis induced by human acetylcholine receptor e subunit immunization in HLA-DR3 transgenic mice","volume":"168","author":"Wu","year":"2015","journal-title":"Immunol. Lett."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1442-200X.1996.tb03459.x","article-title":"Change of immunological parameters in the clinical course of a myasthenia gravis patient with chronic graft-versus-host disease","volume":"38","author":"Hayashi","year":"1996","journal-title":"Acta Paediatr. Jpn."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jnnp.34.5.531","article-title":"Myasthenia gravis occurring in twins","volume":"34","author":"Namba","year":"1971","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fneur.2020.00743","article-title":"Management of juvenile myasthenia gravis","volume":"11","author":"Ramdas","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/cen3.12762","article-title":"Childhood myasthenia gravis in Japan: Pathophysiology and treatment options","volume":"14","author":"Hayashi","year":"2023","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis\u2014Autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jnnp.61.2.207","article-title":"Possible distinct pathogenesis in low responder myasthenia gravis: Association of soluble interleukin-2 receptor with acetylcholine receptor antibody titre or abnormal thymus","volume":"61","author":"Hayashi","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF00686418","article-title":"Myasthenia gravis mit fokaler infiltration der endplattenzone","volume":"2","author":"Wiesendanger","year":"1963","journal-title":"Acta Neuropathol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archneur.1963.00460090043004","article-title":"Muscle biopsy experience in myasthenia gravis","volume":"9","author":"Fenichel","year":"1963","journal-title":"Arch. Neurol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1966.tb45463.x","article-title":"Muscle lesions in myasthenia gravis","volume":"135","author":"Fenichel","year":"1966","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_143","first-page":"934","article-title":"Lymphorrhage localized to the muscle end-plate in myasthenia gravis","volume":"112","author":"Pascuzzi","year":"1988","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.41.9.1497","article-title":"Inflammation at the neuromuscular junction in myasthenia gravis","volume":"41","author":"Maselli","year":"1991","journal-title":"Neurology"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: Quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the endplate in 30 patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology"},{"key":"ref_146","first-page":"131","article-title":"Oosterhuis. Animal model of myasthenia gravis","volume":"Volume 5","author":"Glaser","year":"1984","journal-title":"Myasthenia Gravis"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00697195","article-title":"Induction of morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor","volume":"63","author":"Gomez","year":"1984","journal-title":"Acta Neuropathol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1167\/iovs.14-14422","article-title":"RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment","volume":"55","author":"Zhou","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1873-149X\/30\/4\/43\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:36:43Z","timestamp":1760132203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1873-149X\/30\/4\/43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,2]]},"references-count":149,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["pathophysiology30040043"],"URL":"https:\/\/doi.org\/10.3390\/pathophysiology30040043","relation":{},"ISSN":["1873-149X"],"issn-type":[{"value":"1873-149X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,2]]}}}